Next Article in Journal
Plasma Proteins at the Interface of Dental Implants Modulate Osteoblasts Focal Adhesions Expression and Cytoskeleton Organization
Previous Article in Journal
Functional Layered Double Hydroxide Nanohybrids for Biomedical Imaging
Previous Article in Special Issue
Titanate Nanowires as One-Dimensional Hot Spot Generators for Broadband Au–TiO2 Photocatalysis
Open AccessFeature PaperArticle

Optimization of the Production Process and Product Quality of Titanate Nanotube–Drug Composites

1
Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6., H-6720 Szeged, Hungary
2
Department of Applied and Environmental Chemistry, University of Szeged, Rerrich Béla tér 1., H-6720 Szeged, Hungary
3
Reaction Kinetics and Surface Chemistry Research Group, Hungarian Academy of Sciences-University of Szeged, Rerrich Béla tér 1, H-6720 Szeged, Hungary
*
Author to whom correspondence should be addressed.
Nanomaterials 2019, 9(10), 1406; https://doi.org/10.3390/nano9101406
Received: 17 September 2019 / Accepted: 28 September 2019 / Published: 2 October 2019
(This article belongs to the Special Issue Titanate Nanostructures)
Recently, there has been an increasing interest in the application of nanotubular structures for drug delivery. There are several promising results with carbon nanotubes; however, in light of some toxicity issues, the search for alternative materials has come into focus. The objective of the present study was to investigate the influence of the applied solvent on the composite formation of titanate nanotubes (TNTs) with various drugs in order to improve their pharmacokinetics, such as solubility, stability, and bioavailability. Composites were formed by the dissolution of atenolol (ATN) and hydrochlorothiazide (HCT) in ethanol, methanol, 0.01 M hydrochloric acid or in ethanol, 1M sodium hydroxide, dimethylformamide (DMF), dimethyl sulfoxide (DMSO), respectively, and then they were mixed with a suspension of TNTs under sonication for 30 min and vacuum-dried for 24 h. The structural properties of composites were characterized by SEM, TEM, FT-IR, differential scanning calorimetry (DSC), thermogravimetric (TG) analysis, and optical contact angle (OCA) measurements. Drug release was determined from the fast disintegrating tablets using a dissolution tester coupled with a UV–Vis spectrometer. The results revealed that not only the good solubility of the drug in the applied solvent, but also the high volatility of the solvent, is necessary for an optimal composite-formation process. View Full-Text
Keywords: atenolol; hydrochlorothiazide; titanate nanotubes; composite formation; solvent selection atenolol; hydrochlorothiazide; titanate nanotubes; composite formation; solvent selection
Show Figures

Figure 1

MDPI and ACS Style

Ranjous, Y.; Regdon, G., Jr.; Pintye-Hódi, K.; Varga, T.; Szenti, I.; Kónya, Z.; Sovány, T. Optimization of the Production Process and Product Quality of Titanate Nanotube–Drug Composites. Nanomaterials 2019, 9, 1406.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop